Cybin (HELP) Change in Cash (2020 - 2026)
Cybin's (HELP) quarterly Change in Cash came in at -$37.9 million in Q1 2026, down 4185.44% YoY from $926950.6 in Q1 2025, and down 133.99% on a QoQ basis from $111.4 million in Q4 2025.
Cybin (HELP) Change in Cash (2020 - 2026) Analysis & Trends
Cybin (HELP) has 7 years of Change in Cash data on file, last reported at -$37.9 million in Q1 2026.
- Quarterly Change in Cash fell 4185.44% year-over-year to -$37.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.4 million (up 206.25% YoY) and the FY2026 annual result came in at $63.3 million, up 205.01% from the prior year.
- Change in Cash slipped to -$37.9 million in Q1 2026, from $111.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $126.2 million in Q1 2024 to a low of -$37.9 million in Q1 2026.
- A 5-year average of $9.2 million and a median of -$5.4 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2025 — Change in Cash soared 688.33% — and 2026, when it plunged 4185.44%.
- Tracing HELP's Change in Cash over 5 years: stood at -$5.5 million in 2022, then jumped by 376.89% to $15.3 million in 2023, then slumped by 223.47% to -$18.9 million in 2024, then soared by 688.33% to $111.4 million in 2025, then plunged by 133.99% to -$37.9 million in 2026.
- The last three Change in Cash figures came in at -$37.9 million (Q1 2026), $111.4 million (Q4 2025), and -$34.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | -37.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.87 Mn |
| Dec 31, 2025 | 111.42 Mn |
| Sep 30, 2025 | -34.89 Mn |
| Jun 30, 2025 | 24.77 Mn |
| Mar 31, 2025 | -883,690.09 |
| Dec 31, 2024 | -18.94 Mn |
| Sep 30, 2024 | -19.64 Mn |
| Jun 30, 2024 | -20.23 Mn |
| Mar 31, 2024 | 126.15 Mn |
| Dec 31, 2023 | 15.34 Mn |
| Sep 30, 2023 | 6.46 Mn |
| Jun 30, 2023 | -5.42 Mn |
| Dec 31, 2022 | -5.54 Mn |
| Sep 30, 2022 | -9.75 Mn |
| May 31, 2022 | 6.81 Mn |
| Dec 31, 2021 | -9.20 Mn |
| Sep 30, 2021 | 15.97 Mn |
| Jun 30, 2021 | -7.28 Mn |
| Mar 31, 2021 | 18.99 Mn |
| Dec 31, 2020 | 27.74 Mn |